No abstract available
Keywords:
Sjogren's syndrome; biologic therapies; infections; rheumatic fever; vasculitis.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Editorial on the Research Topic Infection-Related Rheumatic Diseases
References
-
-
Zink A, Manger B, Kaufmann J, Eisterhues C, Krause A, Listing J, et al. . Evaluation of the RABBIT risk score for serious infections. Ann Rheum Dis. (2014) 73:1673–6. 10.1136/annrheumdis-2013-203341
-
DOI
-
PMC
-
PubMed
-
-
Thomas K, Vassilopoulos D. Immunization in patients with inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol. (2016) 30:946–63. 10.1016/j.berh.2016.10.009
-
DOI
-
PubMed
-
-
Yacoub M, Mayosi B, ElGuindy A, Carpentier A, Yusuf S. Eliminating acute rheumatic fever and rheumatic heart disease. Lancet. (2017) 390:212–3. 10.1016/S0140-6736(17)31608-2
-
DOI
-
PubMed
-
-
White H, Walsh W, Brown A, Riddell T, Tonkin A, Jeremy R, et al. . Rheumatic heart disease in indigenous populations. Hear Lung Circ. (2010) 19:273–81. 10.1016/j.hlc.2010.02.019
-
DOI
-
PubMed
-
-
Mutagaywa RK, Wind A, Kamuhabwa A, Cramer MJ, Chillo P, Chamuleau S. Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management. Eur J Clin Invest. (2020) 50:13374. 10.1111/eci.13374
-
DOI
-
PMC
-
PubMed